For its third fiscal quarter (ending September 30), Utah Medical Products Inc (NASDAQ: UTMD) has reported a -5% decline in E.P.S. from $1.08 a year ago to $1.03 in the current quarter. For the latest […]
On 10/29/24, Transcat Inc (NASDAQ: TRNS) stock suffered a major decline of -16.8%, closing at $99.45. Moreover, trading volume in this decline was exceptionally high at 353% of normal. Relative to the market the stock […]
For its third fiscal quarter (ending September 30), Stryker Corp (NYSE: SYK) has reported a 20% increase in E.P.S. from $1.82 a year ago to $2.18 in the current quarter. For the latest four quarters […]
Leggett & Platt Inc (NYSE: LEG) has reported E.P.S. of $0.33 for its third fiscal quarter (ending September 30) versus $0.39 for the same period a year ago — a decline of -15%. For the […]
For its second fiscal quarter (ending September 30), Transcat Inc (NASDAQ: TRNS) has reported a 500% increase in E.P.S. from $0.06 a year ago to $0.36 in the current quarter. E.P.S. were $2.01 for the […]
For its second fiscal quarter (ending September 30), Capital Southwest Corp (NASDAQ: CSWC) has reported a -16% decline in E.P.S. from $0.57 a year ago to $0.48 in the current quarter. E.P.S. were $1.67 for […]
For its third fiscal quarter (ending September 30), Calix Inc (NYSE: CALX) has reported a -123% decline in E.P.S. from $0.26 a year ago to $-0.06 in the current quarter. For the latest four quarters […]
Waste Management Inc. (NYSE: WM) has reported earnings for its third fiscal quarter (ending September 30) of $1.89 versus $1.64 for the same period a year ago — an increase of 15%. For the latest […]
Stock Rating Downgrade The Value Trend Rating for USANA Health Sciences Inc (NYSE: USNA) weakened in the last week from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating […]
SPS Commerce Inc (NASDAQ: SPSC) stock suffered a major decline of -10.7% on 10/25/24. The shares closed at $170.49. Moreover, trading volume in this decline was exceptionally high at 361% of normal. The stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research